Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
More Information Supplier Page
NS11394 is a effective and subtype-selective GABA(A) receptor-positive modulator; possesses a functional efficacy selectivity profile of α(5) > α(3) > α(2) > α(1) at GABA(A) alpha subunit-containing receptors.
More Information Supplier Page
NS11394 is a effective and subtype-selective GABA(A) receptor-positive modulator; possesses a functional efficacy selectivity profile of α(5) > α(3) > α(2) > α(1) at GABA(A) alpha subunit-containing receptors.
More Information Supplier Page NS11394 is a effective and subtype-selective GABA(A) receptor-positive modulator; possesses a functional efficacy selectivity profile of α(5) > α(3) > α(2) > α(1) at GABA(A) alpha subunit-containing receptors.
More Information Supplier Page 
Inauhzin(INZ) is a novel small molecule that effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human Y cells without causing apparently genotoxic stress(IC50=3 uM, in A549 cell).
More Information Supplier Page
Inauhzin(INZ) is a novel small molecule that effectively reactivates p53 by inhibiting SIRT1 activity, promotes p53-dependent apoptosis of human Y cells without causing apparently genotoxic stress(IC50=3 uM, in A549 cell).
More Information Supplier Page 
KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK.
More Information Supplier Page
KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK.
More Information Supplier Page KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK.
More Information Supplier Page KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK.
More Information Supplier Page 
